AnaptysBio Inc (GB:0HFQ)

AnaptysBio (0HFQ) Share Price & Analysis


0HFQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.97 - $29.76
Previous Close$18.97
Average Volume (3M)255.00
Market Cap
Enterprise Value$79.25M
Total Cash (Recent Filing)$431.15M
Total Debt (Recent Filing)$19.06M
Price to Earnings (P/E)N/A
Nov 09, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding26,487,240
10 Day Avg. Volume0
30 Day Avg. Volume255
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)486.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.41
Enterprise Value/Gross Profit7.70
Enterprise Value/Ebitda-0.64
Price Target Upside82.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5




What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest share price was $18.96 and its highest was $29.75 in the past 12 months.
    What is AnaptysBio Inc’s market cap?
    Currently, no data Available
    When is AnaptysBio Inc’s upcoming earnings report date?
    AnaptysBio Inc’s upcoming earnings report date is Nov 09, 2023 which is in 161 days.
      How were AnaptysBio Inc’s earnings last quarter?
      AnaptysBio Inc released its earnings results on May 11, 2023. The company reported -$1.58 earnings per share for the quarter, missing the consensus estimate of -$1.032 by -$0.548.
        Is AnaptysBio Inc overvalued?
        According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AnaptysBio Inc pay dividends?
          AnaptysBio Inc does not currently pay dividends.
          What is AnaptysBio Inc’s EPS estimate?
          AnaptysBio Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AnaptysBio Inc have?
          Currently, no data Available
          What happened to AnaptysBio Inc’s price movement after its last earnings report?
          AnaptysBio Inc reported an EPS of -$1.58 in its last earnings report, missing expectations of -$1.032. Following the earnings report the stock price went down -6.733%.
            Which hedge fund is a major shareholder of AnaptysBio Inc?
            Among the largest hedge funds holding AnaptysBio Inc’s share is Baker Bros Advisors LP. It holds AnaptysBio Inc’s shares valued at 17M.


              AnaptysBio Stock Smart Score

              The AnaptysBio Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              AnaptysBio Inc

              AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.


              Forecast EPS vs Actual EPS

              Similar Stocks
              Price & Change
              Design Therapeutics
              Seres Therapeutics
              IDEAYA Biosciences
              Gossamer Bio

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis